MAPT and Alzheimer disease: Alzheimer’s disease (AD) is a neurodegenerative disease characterized by progressive cognitive decline and the accumulation of two pathological protein aggregates in the brain, amyloid-β (Aβ) plaques and phosphorylated tau tangles.1